share_log

JMP Securities Maintains Market Outperform on Relay Therapeutics, Lowers Price Target to $21

JMP Securities Maintains Market Outperform on Relay Therapeutics, Lowers Price Target to $21

JMP證券維持對relay therapeutics的市場超額表現評級,將價格目標下調至21美元。
Benzinga ·  07/18 07:27

JMP Securities analyst Silvan Tuerkcan maintains Relay Therapeutics (NASDAQ:RLAY) with a Market Outperform and lowers the price target from $24 to $21.

JMP Securities分析師Silvan Tuerkcan認爲Relay Therapeutics(納斯達克股票代碼:RLAY)的市場表現維持爲表現優異,並將價格目標從24美元降至21美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論